Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant

Emerg Infect Dis. 2018 Dec;24(12):2241-2250. doi: 10.3201/eid2412.180937.

Abstract

All hepatitis E virus (HEV) variants reported to infect humans belong to the species Orthohepevirus A (HEV-A). The zoonotic potential of the species Orthohepevirus C (HEV-C), which circulates in rats and is highly divergent from HEV-A, is unknown. We report a liver transplant recipient with hepatitis caused by HEV-C infection. We detected HEV-C RNA in multiple clinical samples and HEV-C antigen in the liver. The complete genome of the HEV-C isolate had 93.7% nt similarity to an HEV-C strain from Vietnam. The patient had preexisting HEV antibodies, which were not protective against HEV-C infection. Ribavirin was an effective treatment, resulting in resolution of hepatitis and clearance of HEV-C viremia. Testing for this zoonotic virus should be performed for immunocompromised and immunocompetent patients with unexplained hepatitis because routine hepatitis E diagnostic tests may miss HEV-C infection. HEV-C is also a potential threat to the blood product supply.

Keywords: HEV; Hong Kong; chronic hepatitis; hepatitis; hepatitis E; immunocompromised; liver transplant; rat hepatitis E virus; rodents; viruses; zoonoses.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / therapeutic use
  • Genome, Viral
  • Genomics / methods
  • Hepatitis E / drug therapy
  • Hepatitis E / epidemiology*
  • Hepatitis E / etiology*
  • Hepatitis E / virology
  • Hepatitis E virus* / classification
  • Hepatitis E virus* / genetics
  • Humans
  • Liver Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Open Reading Frames
  • Rats
  • Transplant Recipients*
  • Treatment Outcome
  • Viral Load
  • Whole Genome Sequencing

Substances

  • Antiviral Agents